Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Invest New Drugs. 2013 Oct 10;31(6):1539–1546. doi: 10.1007/s10637-013-0029-6

Table 3.

Drug-related adverse events, worst grade per patient during Cycle 1

Bortezomib (mg/m2) 0.7
1.0
1.3
1.5
Selected Toxicities G1 G2 G3 G1 G2 G3 G1 G2 G3 G1 G2 G3 Total, % (n=23)
Hematologic
 Thrombocytopenia 2 3* 2 7 (30.4)
 Anemia 1 1 1 3 (13)
Non-Hematologic
 Nausea 2 5 4 1 2 1 15 (65.2)
 Fatigue 3 1 2 2 1 1 1 11 (47.8)
 Constipation 1 3 2 1 7 (30.4)
 Anorexia 1 1 1 2 1 1 7 (30.4)
 Diaphoresis / flushing 3 3 2 8 (34.8)
 Diarrhea 2 2 1 5 (21.7)
 Vomiting 1 2 1 1 5 (21.7)
 Hyponatremia 1 1 (4–3)
*

Two Grade 3 and One Grade 4 Thrombocytopenia

Abbreviations: G Grade